Health | 207633 hits | Jun 26 6:46 am | Posted by: DrCaleb
U.S. health regulator approved GW Pharmaceuticals Plc's epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the U.S. and opening floodgates for more research into the medicinal properties of cannabis.
Comments
You need to be a member of CKA and be logged into the site, to comment on news.